169 related articles for article (PubMed ID: 20660115)
1. Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism.
O'Flaherty L; Adam J; Heather LC; Zhdanov AV; Chung YL; Miranda MX; Croft J; Olpin S; Clarke K; Pugh CW; Griffiths J; Papkovsky D; Ashrafian H; Ratcliffe PJ; Pollard PJ
Hum Mol Genet; 2010 Oct; 19(19):3844-51. PubMed ID: 20660115
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis.
Ashrafian H; O'Flaherty L; Adam J; Steeples V; Chung YL; East P; Vanharanta S; Lehtonen H; Nye E; Hatipoglu E; Miranda M; Howarth K; Shukla D; Troy H; Griffiths J; Spencer-Dene B; Yusuf M; Volpi E; Maxwell PH; Stamp G; Poulsom R; Pugh CW; Costa B; Bardella C; Di Renzo MF; Kotlikoff MI; Launonen V; Aaltonen L; El-Bahrawy M; Tomlinson I; Pollard PJ
Cancer Res; 2010 Nov; 70(22):9153-65. PubMed ID: 20978192
[TBL] [Abstract][Full Text] [Related]
3. Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.
Bardella C; Olivero M; Lorenzato A; Geuna M; Adam J; O'Flaherty L; Rustin P; Tomlinson I; Pollard PJ; Di Renzo MF
Mol Cell Biol; 2012 Aug; 32(15):3081-94. PubMed ID: 22645311
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF.
Koivunen P; Hirsilä M; Remes AM; Hassinen IE; Kivirikko KI; Myllyharju J
J Biol Chem; 2007 Feb; 282(7):4524-4532. PubMed ID: 17182618
[TBL] [Abstract][Full Text] [Related]
5. Differential metabolic consequences of fumarate hydratase and respiratory chain defects.
Raimundo N; Ahtinen J; Fumić K; Barić I; Remes AM; Renkonen R; Lapatto R; Suomalainen A
Biochim Biophys Acta; 2008 May; 1782(5):287-94. PubMed ID: 18313410
[TBL] [Abstract][Full Text] [Related]
6. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.
Sudarshan S; Sourbier C; Kong HS; Block K; Valera Romero VA; Yang Y; Galindo C; Mollapour M; Scroggins B; Goode N; Lee MJ; Gourlay CW; Trepel J; Linehan WM; Neckers L
Mol Cell Biol; 2009 Aug; 29(15):4080-90. PubMed ID: 19470762
[TBL] [Abstract][Full Text] [Related]
7. Fumarate hydratase deficiency and cancer: activation of hypoxia signaling?
Ratcliffe PJ
Cancer Cell; 2007 Apr; 11(4):303-5. PubMed ID: 17418405
[TBL] [Abstract][Full Text] [Related]
8. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
Frezza C; Zheng L; Folger O; Rajagopalan KN; MacKenzie ED; Jerby L; Micaroni M; Chaneton B; Adam J; Hedley A; Kalna G; Tomlinson IP; Pollard PJ; Watson DG; Deberardinis RJ; Shlomi T; Ruppin E; Gottlieb E
Nature; 2011 Aug; 477(7363):225-8. PubMed ID: 21849978
[TBL] [Abstract][Full Text] [Related]
9. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.
Isaacs JS; Jung YJ; Mole DR; Lee S; Torres-Cabala C; Chung YL; Merino M; Trepel J; Zbar B; Toro J; Ratcliffe PJ; Linehan WM; Neckers L
Cancer Cell; 2005 Aug; 8(2):143-53. PubMed ID: 16098467
[TBL] [Abstract][Full Text] [Related]
10. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.
Adam J; Hatipoglu E; O'Flaherty L; Ternette N; Sahgal N; Lockstone H; Baban D; Nye E; Stamp GW; Wolhuter K; Stevens M; Fischer R; Carmeliet P; Maxwell PH; Pugh CW; Frizzell N; Soga T; Kessler BM; El-Bahrawy M; Ratcliffe PJ; Pollard PJ
Cancer Cell; 2011 Oct; 20(4):524-37. PubMed ID: 22014577
[TBL] [Abstract][Full Text] [Related]
11. The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-κB signaling.
Shanmugasundaram K; Nayak B; Shim EH; Livi CB; Block K; Sudarshan S
J Biol Chem; 2014 Aug; 289(35):24691-9. PubMed ID: 25028521
[TBL] [Abstract][Full Text] [Related]
12. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
Pollard PJ; Spencer-Dene B; Shukla D; Howarth K; Nye E; El-Bahrawy M; Deheragoda M; Joannou M; McDonald S; Martin A; Igarashi P; Varsani-Brown S; Rosewell I; Poulsom R; Maxwell P; Stamp GW; Tomlinson IP
Cancer Cell; 2007 Apr; 11(4):311-9. PubMed ID: 17418408
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.
Linehan WM; Rouault TA
Clin Cancer Res; 2013 Jul; 19(13):3345-52. PubMed ID: 23633457
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.
Ternette N; Yang M; Laroyia M; Kitagawa M; O'Flaherty L; Wolhulter K; Igarashi K; Saito K; Kato K; Fischer R; Berquand A; Kessler BM; Lappin T; Frizzell N; Soga T; Adam J; Pollard PJ
Cell Rep; 2013 Mar; 3(3):689-700. PubMed ID: 23499446
[TBL] [Abstract][Full Text] [Related]
15. Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
Ooi A; Furge KA
Chin J Cancer; 2012 Sep; 31(9):413-20. PubMed ID: 22776233
[TBL] [Abstract][Full Text] [Related]
16. A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.
Adam J; Yang M; Bauerschmidt C; Kitagawa M; O'Flaherty L; Maheswaran P; Özkan G; Sahgal N; Baban D; Kato K; Saito K; Iino K; Igarashi K; Stratford M; Pugh C; Tennant DA; Ludwig C; Davies B; Ratcliffe PJ; El-Bahrawy M; Ashrafian H; Soga T; Pollard PJ
Cell Rep; 2013 May; 3(5):1440-8. PubMed ID: 23643539
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma.
Yang Y; Lane AN; Ricketts CJ; Sourbier C; Wei MH; Shuch B; Pike L; Wu M; Rouault TA; Boros LG; Fan TW; Linehan WM
PLoS One; 2013; 8(8):e72179. PubMed ID: 23967283
[TBL] [Abstract][Full Text] [Related]
18. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.
Bardella C; El-Bahrawy M; Frizzell N; Adam J; Ternette N; Hatipoglu E; Howarth K; O'Flaherty L; Roberts I; Turner G; Taylor J; Giaslakiotis K; Macaulay VM; Harris AL; Chandra A; Lehtonen HJ; Launonen V; Aaltonen LA; Pugh CW; Mihai R; Trudgian D; Kessler B; Baynes JW; Ratcliffe PJ; Tomlinson IP; Pollard PJ
J Pathol; 2011 Sep; 225(1):4-11. PubMed ID: 21630274
[TBL] [Abstract][Full Text] [Related]
19. The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.
Tong WH; Sourbier C; Kovtunovych G; Jeong SY; Vira M; Ghosh M; Romero VV; Sougrat R; Vaulont S; Viollet B; Kim YS; Lee S; Trepel J; Srinivasan R; Bratslavsky G; Yang Y; Linehan WM; Rouault TA
Cancer Cell; 2011 Sep; 20(3):315-27. PubMed ID: 21907923
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biochemical heterogeneity associated with fumarase deficiency.
Ottolenghi C; Hubert L; Allanore Y; Brassier A; Altuzarra C; Mellot-Draznieks C; Bekri S; Goldenberg A; Veyrieres S; Boddaert N; Barbier V; Valayannopoulos V; Slama A; Chrétien D; Ricquier D; Marret S; Frebourg T; Rabier D; Munnich A; de Keyzer Y; Toulhoat H; de Lonlay P
Hum Mutat; 2011 Sep; 32(9):1046-52. PubMed ID: 21560188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
